Pulmonary hypertension in thalassemia
- 2 August 2010
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1202 (1) , 205-213
Abstract
Pulmonary hypertension (PH) is common in thalassemia and contributes to mortality. Advancing age and a history of splenectomy are major risk factors in this population. The etiology of PH is multifactorial, involving a complex interaction of platelets, the coagulation system, erythrocytes, and endothelial cells along with inflammatory and vascular mediators. The long-term effect of splenectomy, red cell membrane pathology, coagulation abnormalities, low nitric oxide (NO) bioavailability, excess arginase activity, platelet activation, oxidative stress, iron overload, and chronic hemolysis play a role. The process of hemolysis disables the arginine-NO pathway through the simultaneous release of erythrocyte arginase and cell-free hemoglobin. Both NO and its obligate substrate arginine are rapidly consumed. The biological consequences of hemolysis on NO bioavailability ultimately translate into the clinical manifestations of PH. Guidelines for the management of PH in thalassemia have not yet been established; however, clinical trials are ongoing in an effort to guide future therapy.Keywords
This publication has 55 references indexed in Scilit:
- Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi‐center study of iron overloadAmerican Journal of Hematology, 2007
- Pulmonary hypertension and β-thalassemia major: Report of a case, its treatment, and a review of the literatureAmerican Journal of Hematology, 2006
- Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic functionBritish Journal of Haematology, 2006
- Changing Patterns of Thalassemia WorldwideAnnals of the New York Academy of Sciences, 2005
- Pulmonary Hypertension in β‐ThalassemiaAnnals of the New York Academy of Sciences, 2005
- Heart failure in β-thalassemia syndromes: A decade of progressThe American Journal of Medicine, 2005
- Thalassemia Heart DiseaseChest, 2005
- Survival and Disease Complications in Thalassemia MajorAnnals of the New York Academy of Sciences, 1998
- Pulmonary hypertension in patients with thalassemia majorAmerican Heart Journal, 1997
- Pulmonary Hypertension and Right Heart Failure in Patients With β-Thalassemia IntermediaChest, 1995